After completing my PhD at the Department of Neurosciences at the University of Cambridge, I started working at the Stroke Research Group as a Clinical Trial Coordinator in August 2019. I am mainly involved in the ‘DNA Lacunar 2’ project which focuses on looking for genes causing lacunar strokes with small vessel disease (SVD) that is now recognised as the main cause of vascular cognitive impairment and dementia. I am also working on the ‘Apathy in Stroke’ study which aims to investigate neural mechanisms for the emergence of apathy in SVD with the hope that new therapeutic targets can be proposed and improve patients quality of life. Another interesting research project that I am collaborating on is ‘Rates, Risks and Routes to Reduce Vascular Dementia (R4VaD)’. Stroke commonly affects cognition and, by definition, vascular dementia is driven by stroke disease in some way. This study targets to recruit a wide range of patients with stroke, presenting to geographically diverse UK hospitals, into a longitudinal study to determine rates of, and risk factors for, cognitive and related impairments after stroke, to assess mechanisms and improve prediction models.
2019 – Ph.D., Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
2011 – M.Sc., Cognitive Neurosciences, Anglia Ruskin University, Cambridge, United Kingdom.
2007 – B.Sc., (Hons), Psychology, Universidad de Oviedo, Oviedo, Spain.